Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021
12 11월 2021 - 9:30AM
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the
“Company”), a specialty pharmaceutical company, today announced
that the Company will release its 2021 third quarter financial
results on Monday, November 15, 2021, after the close of the U.S.
financial markets.
Brian Markison, Chief Executive Officer, James “JD” Schaub,
Chief Operating Officer, and Andrew Einhorn, Chief Financial
Officer, will host a conference call as follows:
Date |
Monday, November 15, 2021 |
Time |
4:30 p.m. ET |
Toll free (U.S.) |
(866) 672-5029 |
International |
(409) 217-8312 |
Conference ID |
57399556 |
Webcast (live and replay) |
www.osmotica.com under the “Investor & News” section |
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a specialty
pharmaceutical company focused on the development and
commercialization of products that target markets with underserved
patient populations. RVL Pharmaceuticals, Inc. is the Company’s
ophthalmic subsidiary supporting UPNEEQ®.
Osmotica has operations in the United States and Hungary.
Investor and Media Relations for Osmotica
Pharmaceuticals plcLisa M. WilsonIn-Site Communications,
Inc.T: 212-452-2793E: lwilson@insitecony.com
Osmotica Pharmaceuticals (NASDAQ:OSMT)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Osmotica Pharmaceuticals (NASDAQ:OSMT)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
Osmotica Pharmaceuticals PLC (나스닥)의 실시간 뉴스: 최근 기사 0
More News Articles